We are live on ! Find out more
EP

Elkfork Partners Portfolio holdings

AUM $4.11B
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
-13.25%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.4%
5 Year Est. Return
10 Year Est. Return
AUM
$3.55B
AUM Growth
-$661M
Cap. Flow
-$52.1M
Cap. Flow %
-1.47%
Top 10 Hldgs %
24.55%
Holding
1,098
New
85
Increased
374
Reduced
258
Closed
83

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$32.1M
2
COP icon
ConocoPhillips
COP
+$17.9M
3
LIN icon
Linde
LIN
+$17.1M
4
XOM icon
ExxonMobil
XOM
+$15.1M
5
FTNT icon
Fortinet
FTNT
+$11.1M

Sector Composition

Rank Sector Weight
1 Technology 18.48%
2 Financials 15.73%
3 Healthcare 13.18%
4 Consumer Discretionary 13.17%
5 Industrials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
226
Colgate-Palmolive
CL
$73.1B
$2.66M 0.08%
44,710
+3,060
+7% +$191K
PAYX icon
227
Paychex
PAYX
$41.6B
$2.64M 0.07%
40,458
-1,232
-3% -$83.5K
ATH
228
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$2.61M 0.07%
65,450
-15,994
-20% -$720K
NBL
229
DELISTED
Noble Energy, Inc.
NBL
$2.52M 0.07%
134,552
+73,678
+121% +$1.89M
STAA icon
230
STAAR Surgical
STAA
$1.21B
$2.51M 0.07%
78,628
-528
-0.7% -$20.6K
RF icon
231
Regions Financial
RF
$26.4B
$2.51M 0.07%
187,396
-166,562
-47% -$2.68M
ADP icon
232
Automatic Data Processing
ADP
$106B
$2.45M 0.07%
18,678
+1,012
+6% +$143K
MKC icon
233
McCormick & Company Non-Voting
MKC
$13.7B
$2.44M 0.07%
35,112
+784
+2% +$56.2K
CHD icon
234
Church & Dwight Co
CHD
$23.4B
$2.41M 0.07%
36,680
+15,120
+70% +$957K
AEE icon
235
Ameren
AEE
$30.3B
$2.41M 0.07%
36,904
+6,552
+22% +$437K
MDT icon
236
Medtronic
MDT
$109B
$2.32M 0.07%
25,520
-5,852
-19% -$547K
PB icon
237
Prosperity Bancshares
PB
$8.97B
$2.3M 0.06%
36,890
-3,774
-9% -$249K
MRSH
238
Marsh
MRSH
$90.5B
$2.29M 0.06%
28,784
-588
-2% -$49K
EVRG icon
239
Evergy
EVRG
$19.1B
$2.27M 0.06%
40,018
+31,504
+370% +$1.82M
NEM icon
240
Newmont
NEM
$98.7B
$2.25M 0.06%
64,790
-49,500
-43% -$1.6M
VICI icon
241
VICI Properties
VICI
$29B
$2.23M 0.06%
118,636
-2,240
-2% -$47.1K
WEC icon
242
WEC Energy
WEC
$35.7B
$2.21M 0.06%
31,976
+15,792
+98% +$1.11M
QCOM icon
243
Qualcomm
QCOM
$155B
$2.18M 0.06%
38,284
-2,176
-5% -$132K
WRI
244
DELISTED
Weingarten Realty Investors
WRI
$2.13M 0.06%
86,020
+45,016
+110% +$1.25M
IBKR icon
245
Interactive Brokers
IBKR
$39.2B
$2.13M 0.06%
155,672
+27,632
+22% +$369K
FLG
246
Flagstar Bank National Association
FLG
$5.93B
$2.12M 0.06%
75,197
+7,775
+12% +$227K
VAR
247
DELISTED
Varian Medical Systems, Inc.
VAR
$2.11M 0.06%
18,620
-13,328
-42% -$1.52M
ICUI icon
248
ICU Medical
ICUI
$4.21B
$2.09M 0.06%
9,112
+816
+10% +$201K
ATO icon
249
Atmos Energy
ATO
$28.8B
$2.07M 0.06%
22,338
-14,790
-40% -$1.41M
PPC icon
250
Pilgrim's Pride
PPC
$6.51B
$2.06M 0.06%
132,608
+88,284
+199% +$1.58M

Similar funds

Elkfork Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Elkfork Partners held 1,098 positions worth $3.55B, down 16% from $4.21B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Elkfork Partners's Q4 2018 filing shows 85 new, 374 increased, 258 reduced and 83 closed positions. Its largest new stake was Linde: 108,108 shares worth $16.9M. The largest sale was Express Scripts Holding Company, an estimated $51.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Elkfork Partners's largest Q4 2018 buy was Linde: 108,108 shares worth $16.9M.
  • Elkfork Partners added most to Cigna in Q4 2018, an estimated $32.1M increase.
  • Elkfork Partners's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $16.4M.
  • Elkfork Partners fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $51.2M.
  • Elkfork Partners's ten largest holdings make up 25% of its $3.55B portfolio in Q4 2018.
  • Elkfork Partners opened 85 new positions and closed 83 in Q4 2018.
  • Elkfork Partners's portfolio value fell 16% quarter-over-quarter to $3.55B.

Based on Elkfork Partners's 13F filing for Q4 2018, filed 13 Feb 2019.